???global.info.a_carregar???
Identificação

Identificação pessoal

Nome completo
Patrícia Alexandra Fernandes Conde

Nomes de citação

  • Conde, Patrícia

Identificadores de autor

Ciência ID
B816-8297-3C0D
ORCID iD
0009-0002-5478-5117

Telefones

Telefone
  • 214403500 Ext.: 62799 (Profissional)

Moradas

  • Av. da República, Quinta do Marquês , 2780-157 , Oeiras, Lisboa, Portugal (Profissional)

Domínios de atuação

  • Ciências Agrárias

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Inglês Utilizador elementar (A2) Utilizador independente (B1) Utilizador elementar (A2) Utilizador independente (B1) Utilizador elementar (A2)
Português (Idioma materno)
Francês Utilizador elementar (A2) Utilizador independente (B1) Utilizador elementar (A2) Utilizador independente (B1) Utilizador independente (B1)
Formação
Grau Classificação
2005/10/13 - 2008/06/16
Concluído
 Saúde Pública (Mestrado)
Universidade Nova de Lisboa Escola Nacional de Saúde Pública, Portugal
"Diarreias em Portugal : contributo para um melhor conhecimento da sua frequência, características e agentes etiológicos" (TESE/DISSERTAÇÃO)
 16
1995/10/01 - 2000/07/28
Concluído
 Engenharia biotécnologica (Licenciatura)
Universidade Lusófona de Humanidades e Tecnologias, Portugal
"Estudo do agente patogénico, Escherichia coli O157:H7, através do método de separação imunomagnética (IMS) e do sistema automatizado VIDAS, em amostras de leites, carnes e seus derivados." (TESE/DISSERTAÇÃO)
 13
Percurso profissional

Outras Carreiras

Categoria Profissional
Instituição de acolhimento 		Empregador
2022/10/01 - Atual Técnico Superior (Técnico Superior) Instituto Nacional de Recursos Biológicos, Portugal
Instituto Nacional de Recursos Biológicos, Portugal
2019/01/02 - 2022/09/30 Técnico Superior (Técnico Superior) Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
Instituto Nacional de Saúde Doutor Ricardo Jorge IP Departamento de Doenças Infeciosas, Portugal

Outros

Categoria Profissional
Instituição de acolhimento 		Empregador
2004/01/04 - 2018/12/31 Bolseira de Investigação Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
Instituto Nacional de Saúde Doutor Ricardo Jorge IP Departamento de Doenças Infeciosas, Portugal
Produções

Publicações

Artigo em revista
  1. Kissling E; Hooiveld M; Martínez-Baz I; Mazagatos C; William N; Vilcu AM; Kooijman MN; et al. "Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021.". Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin (2022): http://europepmc.org/abstract/med/35620997.
    10.2807/1560-7917.es.2022.27.21.2101104
  2. Esther Kissling; Mariette Hooiveld; Virginia Sandonis Martín; Iván Martínez-Baz; Naoma William; Ana-Maria Vilcu; Clara Mazagatos; et al. "Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021". Eurosurveillance (2021): http://dx.doi.org/10.2807/1560-7917.es.2021.26.29.2100670.
    10.2807/1560-7917.es.2021.26.29.2100670
  3. Ausenda Machado; Verónica Gomez; António Panarra; Jose Poças; Rita Corte-Real; Maria João Peres; Baltazar Nunes; Em Representação do EVA Hospital Group. "Implementing an Influenza Vaccine Effectiveness Study in a Hospital Context in Portugal: The EVA Hospital Project". Acta Médica Portuguesa (2021): http://dx.doi.org/10.20344/amp.13438.
    10.20344/amp.13438
  4. Rose A; Kissling E; Emborg HD; Larrauri A; McMenamin J; Pozo F; Trebbien R; et al. "Interim 2019/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020.". Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin (2020): http://europepmc.org/abstract/med/32183932.
    10.2807/1560-7917.es.2020.25.10.2000153
  5. Esther Kissling; Francisco Pozo; Silke Buda; Ana-Maria Vilcu; Caterina Rizzo; Alin Gherasim; Judit Krisztina Horváth; et al. "Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016–17 and 2017–18)". Vaccine: X (2019): http://dx.doi.org/10.1016/j.jvacx.2019.100042.
    10.1016/j.jvacx.2019.100042
  6. Esther Kissling; Francisco Pozo; Silke Buda; Ana-Maria Vilcu; Alin Gherasim; Mia Brytting; Lisa Domegan; et al. "Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15–64-year-olds in Europe: exploration by birth cohort". Eurosurveillance (2019): http://dx.doi.org/10.2807/1560-7917.es.2019.24.48.1900604.
    10.2807/1560-7917.es.2019.24.48.1900604
  7. Sáez-López E; Pechirra P; Costa I; Cristóvão P; Conde P; Machado A; Rodrigues AP; Guiomar R. "Performance of surveillance case definitions for respiratory syncytial virus infections through the sentinel influenza surveillance system, Portugal, 2010 to 2018.". Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin (2019): http://europepmc.org/abstract/med/31718741.
    10.2807/1560-7917.es.2019.24.45.1900140
  8. Sáez-López E; Cristóvão P; Costa I; Pechirra P; Conde P; Guiomar R; Portuguese Laboratory Network for the Diagnosis of Influenza Infection; Peres MJ; Rodrigues D. "Epidemiology and genetic variability of respiratory syncytial virus in Portugal, 2014-2018.". Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology (2019): http://europepmc.org/abstract/med/31707201.
    10.1016/j.jcv.2019.104200
  9. Esther Kissling; Angela Rose; Hanne-Dorthe Emborg; Alin Gherasim; Richard Pebody; Francisco Pozo; Ramona Trebbien; et al. "Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019". Eurosurveillance (2019): http://dx.doi.org/10.2807/1560-7917.es.2019.24.1900121.
    10.2807/1560-7917.es.2019.24.1900121
  10. Angeliki Melidou; Eeva Broberg; Cornelia Adlhoch; René Snacken; Pasi Penttinen; Dmitriy Pereyaslov; Caroline Brown; et al. "Erratum to “Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe – Contribution of surveillance data from World Health Organization (WHO) European region to the WHO vaccine composition consultation for northern hemisphere 2017/18” [Vaccine 35 (2017) 4828–4835]". Vaccine (2018): http://dx.doi.org/10.1016/j.vaccine.2017.12.039.
    10.1016/j.vaccine.2017.12.039
  11. Esther Kissling; Valenciano M; Pozo F; Vilcu AM; Reuss A; Caterina Rizzo; Amparo Larrauri; et al. "2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children.". Influenza and other respiratory viruses (2018): https://europepmc.org/articles/PMC6005601.
    10.1111/irv.12520
  12. Angeliki Melidou; Eeva Broberg. "Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe – Contribution of surveillance data from World Health Organization (WHO) European Region to the WHO vaccine composition consultation for northern hemisphere 2017/18". Vaccine (2017): http://dx.doi.org/10.1016/j.vaccine.2017.07.057.
    10.1016/j.vaccine.2017.07.057
  13. Guiomar R; Pereira da Silva S; Conde P; Cristóvão P; Maia AC; Pechirra P; Rodrigues AP; Nunes B; Cunha M. "Cross-protection to new drifted influenza A(H3) viruses and prevalence of protective antibodies to seasonal influenza, during 2014 in Portugal.". Vaccine (2017): http://europepmc.org/abstract/med/28318771.
    10.1016/j.vaccine.2017.02.019
  14. Esther Kissling; Marc Rondy; I-MOVE/I-MOVE+ study team. "Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe". Eurosurveillance (2017): http://dx.doi.org/10.2807/1560-7917.es.2017.22.7.30464.
    10.2807/1560-7917.es.2017.22.7.30464
  15. Guiomar R; Pechirra P; Cristóvão P; Costa I; Conde P; Silva S; Nunes B; Rodrigues A. "Influenza surveillance during 2015/2016 season in Portugal". Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology (2016): http://europepmc.org/abstract/PMC/PMC7130101.
  16. Gaio V; Nunes B; Pechirra P; Conde P; Guiomar R; Dias CM; Barreto M. "Hospitalization Risk Due to Respiratory Illness Associated with Genetic Variation at IFITM3 in Patients with Influenza A(H1N1)pdm09 Infection: A Case-Control Study.". PloS one (2016): http://europepmc.org/abstract/med/27351739.
    10.1371/journal.pone.0158181
  17. Eeva Broberg; Angeliki Melidou; Katarina Prosenc; Karoline Bragstad; Olav Hungnes; on behalf of the WHO European Region and the European Influenza Surveillance Network members of the reporting countries. "Predominance of influenza A(H1N1)pdm09 virus genetic subclade 6B.1 and influenza B/Victoria lineage viruses at the start of the 2015/16 influenza season in Europe". Eurosurveillance (2016): http://dx.doi.org/10.2807/1560-7917.es.2016.21.13.30184.
    10.2807/1560-7917.es.2016.21.13.30184
  18. Beauté J; Zucs P; Korsun N; Bragstad K; Enouf V; Kossyvakis A; Griškevicius A; et al. "Age-specific differences in influenza virus type and subtype distribution in the 2012/2013 season in 12 European countries.". Epidemiology and infection (2015): http://europepmc.org/abstract/med/25648399.
    10.1017/s0950268814003422
  19. Nunes B; Machado A; Guiomar R; Pechirra P; Conde P; Cristovão P; Falcão I. "Estimates of 2012/13 influenza vaccine effectiveness using the case test-negative control design with different influenza negative control groups.". Vaccine (2014): http://europepmc.org/abstract/med/24962756.
    10.1016/j.vaccine.2014.06.053
  20. Valenciano M; Kissling E; I-MOVE Case-Control Study Team. "Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13.". Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin (2013): http://europepmc.org/abstract/med/23449183.
  21. Valenciano M; Ciancio B; I-MOVE study team. "I-MOVE: a European network to measure the effectiveness of influenza vaccines.". Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin (2012): https://doi.org/10.2807/ese.17.39.20281-en.
    10.2807/ese.17.39.20281-en
  22. Pechirra P; Gonçalves P; Conde P; Nunes B; Guiomar R. "[National Influenza Surveillance Programme: results of influenza activity in Portugal in the 2010/2011 season].". Acta medica portuguesa (2012): http://europepmc.org/abstract/med/23211197.
  23. Collective Portuguese Laboratory Network for t. "Contribution of the Portuguese Laboratory Network for the Diagnosis of Influenza A(H1N1)pdm09 Infection during the 2009/10 and 2010/11 influenza seasons". Eurosurveillance (2012): http://dx.doi.org/10.2807/ese.17.27.20211-en.
    10.2807/ese.17.27.20211-en
  24. Kissling E; Valenciano M; I-MOVE Case-Control Studies Team. "Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12.". Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin (2012): http://europepmc.org/abstract/med/22516046.
  25. E Kissling; M Valenciano; Collective I-MOVE case–control studies team. "Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case–control study". Eurosurveillance (2011): http://dx.doi.org/10.2807/ese.16.11.19818-en.
    10.2807/ese.16.11.19818-en